Tampere, Finland

Leena Huhti

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2014.


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leena Huhti: Innovator in Vaccine Development

Introduction

Leena Huhti is a prominent inventor based in Tampere, Finland. She has made significant contributions to the field of vaccine development, particularly in the area of viral infections. Her work focuses on creating innovative solutions to combat norovirus and rotavirus infections.

Latest Patents

Leena Huhti holds a patent for a combined norovirus and rotavirus vaccine. The patent, titled "Norovirus capsid and rotavirus VP6 protein for use as combined vaccine," relates to a method of preparing combination vaccine compositions. This invention aims to prevent norovirus and rotavirus infections, as well as viral-induced diarrheal and vomiting diseases in humans. The vaccine comprises a mixture of norovirus virus-like particles (VLPs) and rotavirus recombinant VP6 protein or double-layered VP2/VP6 VLPs. Additionally, the invention includes methods for inducing an immune response.

Career Highlights

Throughout her career, Leena Huhti has demonstrated a strong commitment to advancing medical science. Her innovative approach to vaccine development has positioned her as a key figure in the fight against viral infections. With her expertise, she has contributed to the understanding and prevention of diseases that significantly impact public health.

Collaborations

Leena has collaborated with notable professionals in her field, including Kirsi Nurminen and Timo Vesikari. These partnerships have enhanced her research and contributed to the successful development of her patented vaccine.

Conclusion

Leena Huhti's work in vaccine development exemplifies her dedication to improving public health through innovation. Her contributions to the field, particularly with her patented combined vaccine, highlight the importance of scientific research in combating viral infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…